European Epidemiological Forum - Relatori

Christian J. Agboton currently serves as Senior Global Brand Medical Director at Takeda based in Zurich, Switzerland. He previously served as Medical Director of Biosimilars Immunology / inflammation at Sandoz and Hospira/Pfizer. Christian also worked at GSK vaccines, Merck Serono and UCB Pharma in Clinical and Medical Affairs roles. Channeling innovation to deliver evidence while keeping quality and timelines has always been at the heart of his approach to data generation. Christian is Fellow of the Royal Faculty of Pharmaceutical Medicine (FFPM).

Dr. Maurille Feudjo Tepie is an Observational Research Director at Amgen and leads the Amgen European Team of the Centre for Observational Research. Prior to joining Amgen in 2009, he spent six years in the Worldwide Epidemiology Department at GSK. Maurille obtained his PhD in Medical Statistics from the London School of Hygiene and Tropical Medicine and then completed a one year post-doctoral fellowship working on a collaborative methodological project between the Worldwide Epidemiology Department of GSK and the London School of Hygiene and Tropical Medicine, under the supervision of Profs Stuart Pocock and Steven Evans. He has considerable experience designing and executing appropriate observational research strategies to inform drug development and drug commercialization and; is a keen contributor to scientific discussions pertaining to the challenges and/or opportunities offered to regulators, payers, academics, prescribers and to the bio-pharmaceutical industry by advances in computing science and the increased availability of real world data. He has been active in European-wide initiatives aimed at improving biomedical research (IMI PROTECT and EMIF) and is also the chair of the PSI Epidemiology Special Interest Group.

Qualified with a hospital pharmacy background, Omar has been working as the Formulary Advisor for Surrey & Sussex Healthcare NHS Trust for over 15 years, sitting on the regional Joint Drugs & Therapeutics Committee as well as the CCG/Commissioning Prescribing Clinical Network.
Omar has been a visiting Lecturer at UCLH Pharmacy Programme and was both Lecturer & Examiner on the Independent Prescribing V300 Course at the University of Surrey and has over 30 publications to date. He has been appointed as Visiting Lecturer on Value Based Pricing & Innovative Contracting at the University of Portsmouth, is an Editorial Content Adviser to Guidelines, and has recently been invited to the position of Associate Editor to the Canadian Journal of Population Therapeutics & Clinical Pharmacology.
Omar has served a position on the External Reference Group on Cost Impact Modelling for NICE for 6 years and was subsequently appointed Panel Member for the newly formed Adoption & Impact Program Reference for NICE. He advises foreign investors (US Embassy) on ‘Value Based Assessments (hosted by the UK Department of Trade & Industry) and recently delivered a Healthcare NHS Reform program to over 40 Healthcare Insurance Provider delegates visiting from the US.
Last year he was invited to address the Italian Healthcare Senate [Senato della Repubblica] on Pharmaco-economic Evaluation & Sustainability Models of Healthcare and featured at the Westminster Health Forum Keynote Seminars [chaired by Lord Howe, All Party Parliamentary Group on Pharmacy] on the Future for Pharmacy Commissioning, Organisation & Delivery.
At this current time he has embarked on a PhD with his doctorate thesis entitled “Value Based Pricing & Outcomes Based, Innovative Contracting of New Medicines”.

Dr Vasa Curcin is a Reader in Health Informatics at King’s College London and leads the Biomedical Informatics Group, focusing on reproducibility solutions based on data provenance, embedding clinical trials into routine practice, decision support systems as means of implementing Learning Health Systems in practice, and machine learning methods for detecting depression and anxiety disorders from social network behaviours.
Vasa completed his PhD at Imperial College London on semantics of scientific workflow systems. While working as a Bioinformatics Product Manager at InforSense Ltd, the application of his thesis to large real-world patient databases resulted in one of the earliest workflow-based phenotyping tools that has been used in both academic and industrial settings. He was a Farr Future Leader, is the King’s lead for Health Data Research UK network’s Phenomics and Clinical Trial Informatics themes. He is a co-director of the DRIVE-Health Centre for Doctoral Training in Data-Driven Health.

Fabrizio works as researcher and interventional cardiologist in the Division of Cardiology of the University of Turin. His main interests of research range from management of Acute Coronary Syndromes (ACSs) both from an interventional point of view and secondary prevention to Transcatheter Aortic Valve Implantation (TAVI) focusing on the impact of Artificial Intelligence (AI) on medicine. He has published over 300 papers with an H-Index of 45 (Scopus).
He has taught several courses on statistics for non-statisticians, medical reading/writing combining both clinical and scientific skills.

Matteo Gabetta, PhD, is R&D Manager in Biomeris, a company that provides IT solutions for the management and analysis of data in the biomedical field. He obtained a master’s degree in computer engineering and a PhD in bioengineering at the University of Pavia. He is currently involved in data integration projects in the Life Science field aimed at supporting medical research and clinical practice.

Pall Jonsson is Programme Director for Data at the National Institute for Health and Care Excellence.  Pall has a background in research and experience in synthesising, analysing and appraising scientific and clinical evidence, gained through work in academia, not-for-profit sector and the pharmaceutical industry.  He has doctorate in biochemistry and bioinformatics from University College London.

Kelly H. Zou, Ph.D., PStat® is Head of Global Medical Analytics and Real World Evidence, Viatris. She is an elected Fellow of the American Statistical Association and an Accredited Professional Statistician. Previously at Pfizer Inc, she was Vice President and Head of Medical Analytics & Insights; Senior Director of Real World Evidence, Group Lead of Methods & Algorithms and Analytic Science Lead; Senior Director of Statistics. She was Associate Professor of Radiology at Harvard Medical School, as well as Director of Biostatistics at its affiliated teaching hospitals. She was Associate Director of Rates at Barclays Capital. She received both MA and PhD degrees in Statistics from the University of Rochester and completed her Postdoctoral Fellowship at Harvard. Her research interests include health policy, real world evidence, signal detection, and artificial intelligence, with over 150 professional articles and 4 books. She was featured as an Outstanding Woman in Data Analytics by Forbes, an Inspirational Women in Statistics & Data Science by Wiley and the Royal Statistical Society, and an Accomplished Woman in Statistics and Data Science by the American Statistical Association.